Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations

Calabrese, F.; Lunardi, F.; Giacometti, C.; Marulli, G.; Gnoato, M.; Pontisso, P.; Saetta, M.; Valente, M.; Rea, F.; Perissinotto, E.; Agostini, C.
September 2008
Thorax;Sep2008, Vol. 63 Issue 9, p796
Academic Journal
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder with a poor prognosis. Epithelial instability is a crucial step in the development and progression of the disease, including neoplastic transformation. Few tissue markers for epithelial instability have been reported in IPF. Squamous cell carcinoma antigen (SCCA) is a serine protease inhibitor typically expressed by dysplastic and neoplastic cells of epithelial origin, more often in squamous cell tumours. At present, no information is available on its expression in IPF. Methods: SCCA and transforming growth factor 13 (TGFβ) expression in surgical lung biopsies from 22 patients with IPF and 20 control cases was examined. An in vitro study using A549 pneumocytes was also conducted to investigate the relationship between SCCA and TGFβ expression. SCCA and TGFβ epithelial expression was evaluated by immunohistochemistry and reverse transcription-PCR (RT-PCR). SCCA values were correlated with different pathological and clinical parameters. Time course analysis of TGFβ expression in A549 pneumocytes incubated with different SCCA concentrations was assessed by real time RT-PCR. Results: SCCA was expressed in many metaplastic alveolar epithelial cells in all IPF cases with a mean value of 24.9% while it was seen in only two control patients in up to 5% of metaplastic cells. In patients with IPF, SCCA correlated positively with extension of fibroblastic foci (r = 0.49, p = 0.02), expression of TGFβ (r = 0.78, p<0.0001) and with carbon monoxide transfer factor decline after 9 months of follow-up (r = 0.59, p = 0.01). In vitro experiments showed that incubation of cultured cells with SCCA induced TGF)3 expression, with a peak at 24 h. Conclusion: Our findings provide for the first time a potential mechanism by which SCCA secreted from metaplastic epithelial cells may exert a profibrotic effect in IPF. SCCA could be an important biomarker in this incurable disease.


Related Articles

  • Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer. Bae Kwon Jeong; Seung Jae Huh; Doo Ho Choi; WonPark; Duk Soo Bae; Byoung-Gie Kim // Cancer Research & Treatment;Mar2013, Vol. 45 Issue 1, p48 

    Purpose In some unusual cases, in patients with cervical cancer, an elevation of squamous cell carcinoma antigen (SCC-Ag) was not observed at diagnosis but was observed on recurrence, or vice versa. The objective of this study was to identify patient-, disease-, and treatment-related factors...

  • Search for Amniotic Fluid-Specific Markers: Novel Biomarker Candidates for Amniotic Fluid Embolism. Kobayashi, Hiroshi; Naruse, Katsuhiko; Sado, Toshiyuki; Noguchi, Taketoshi; Yoshida, Shozo; Shigetomi, Hiroshi; Onogi, Akira; Oi, Hidekazu // Open Women's Health Journal;2011, Vol. 5, p7 

    Objective: Amniotic fluid embolism (AFE) is a catastrophic syndrome. The amniotic fluid (AF)-specific antigens might be assessed in maternal serum when these proteins abruptly enter maternal circulation. The aims of this study were 1) to review a conventional marker for diagnosis of AFE, and 2)...

  • A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma. Ries, Jutta; Mollaoglu, Nur; Toyoshima, Takeshi; Vairaktaris, Eleftherios; Neukam, Friedrich W.; Ponader, Sabine; Nkenke, Emeka // Disease Markers;2009, Vol. 27 Issue 2, p75 

    Objective: Melanoma associated antigens-A (MAGE-A) expression is highly specific to cancer cells. Thus, they can be the most suitable targets for the diagnosis of malignancy. The aim of this study was to evaluate the sensitivity of multiple MAGE-A expression analysis for the diagnosis of oral...

  • Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor. Kumai, Takumi; Oikawa, Kensuke; Aoki, Naoko; Kimura, Shoji; Harabuchi, Yasuaki; Celis, Esteban; Kobayashi, Hiroya // Journal of Translational Medicine;2014, Vol. 12 Issue 1, p1 

    Background EGFR-targeted therapy is an attractive option for head and neck squamous cell carcinoma patients. We have recently reported the use of EGFR inhibitors as an adjunct treatment to enhance HLA-DR expression in tumor cells to improve cancer immunotherapy. Nevertheless, we observed that...

  • Squamous cell carcinoma antigen in cervical cancer and beyond. Byoung-Gie Kim // Journal of Gynecologic Oncology;2013, Vol. 24 Issue 4, p291 

    The author reflects on a study which evaluates the effectiveness of squamous cell carcinoma antigen (SCC-Ag) in the treatment of squamous cell carcinoma. He states that level of serum SCC-Ag before surgery provides preoperative estimation for adjuvant radiotherapy. He concludes that SCC-Ag is a...

  • A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature. Russo, N; Wang, X; Liu, M; Banerjee, R; Goto, M; Scanlon, C; Metwally, T; Inglehart, R C; Tsodikov, A; Duffy, S; Van Tubergen, E; Bradford, C; Carey, T; Wolf, G; Chinnaiyan, A M; D'Silva, N J // Oncogene;10/17/2013, Vol. 32 Issue 42, p5026 

    Despite the dismal prognosis for patients with squamous cell carcinoma of the head and neck (SCCHN), there have been no novel treatments in over 40 years. Identification of novel tumor antigens in SCCHN will facilitate the identification of potential novel treatment targets. Tumor antigens are...

  • Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor - the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+... Starska, Katarzyna; Głowacka, Ewa; Kulig, Andrzej; Lewy-Trenda, Iwona; Bryś, Magdalena; Lewkowicz, Przemysław // Folia Histochemica et Cytobiologica;2011, Vol. 49 Issue 4, p593 

    One of the most important challenges in contemporary oncology is to find objective biomarkers of tumor aggressiveness, which help to identify more invasive phenotypes of the carcinoma. The purpose of this study was to investigate the relationships between the early and the late activation...

  • Applicability of Biomarkers for Differentiation of Inverted Papilloma Assigned for Endoscopic Surgery. Ramadan, Mohammad M. Fatthy; Mahmoud, Ahmed Abd Elrahman; Elsheikh, Ahmed M. Abdelhady; Elhabashy, Hatem Salah Eldin // Trends in Medical Research;2013, Vol. 8 Issue 1, p16 

    The aim of this study is to evaluate safety and feasibility of endoscopic surgery for management of nasal Inverted Papilloma (IP). The study estimated tissue extract Epidermal Growth Factor Receptor (EGFR) and serum Squamous Cell Carcinoma Antigen (SCCA) levels to determine their applicability...

  • Quantitative analysis of serum dipeptidyl peptidase IV enzyme in oral squamous cell carcinoma. Kandekar, Prashant V.; Tamgadge, Avinash; Meshram, Suresh // Der Pharma Chemica;2014, Vol. 6 Issue 1, p312 

    Dipeptidyl Peptidase IV (DPP IV) is an enzyme which splits N-terminal X-proline from peptides. The objective of this study was to present a reliable test to quantitatively estimate the serum Dipeptidyl Peptidase IV enzyme in oral cancer patients and to ascertain if Dipeptidyl Peptidase IV can be...


Read the Article


Sign out of this library

Other Topics